Another Pfizer breadcrumb (previously discussed) is that they are very tight with Parexel, having maintained a decade long partnership with them.
I've been convinced Sarepta are the more likely suitor, but won't be surprised...
Good luck!
Chart, page-4234
-
- There are more pages in this discussion • 1,672 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 251000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 163520 | 2 |
View Market Depth
| Last trade - 10.06am 04/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable